Main distributor to Brazil and Latin America for analytical reference substances  |  Welcome! Olá! Hola! Español  |  +1.919.484.7555
You are here: Home /Healthcare, USA /Paying $3B – GSK tops US criminal, civil settlements for off-label, other schemes

Paying $3B – GSK tops US criminal, civil settlements for off-label, other schemes

by JMC on July 6, 2012

Beating the competition is the name of the game in business. But GlaxoSmithKline’s $3 billion settlement with the US government to resolve criminal and civil charges1,2 – topping rival New York-based Pfizer’s $2.3 billion deal3 – is not likely what the drug giant had in mind for outdoing its competitors…

Previous post:

Next post: